| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
Department of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder, Boulder, Colorado 80309
Received 10 April 2007/ Returned for modification 9 May 2007/ Accepted 9 August 2007
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
In humans, the essential splicing factor U2AF is a heterodimer of a large protein subunit (U2AF65) and a small protein subunit (U2AF35). U2AF65 binds to the Py tract (62), and U2AF35 recognizes the 3' SS (33, 61, 65). Both subunits of U2AF are essential for viability in many model organisms, such as the zebrafish, the fruit fly, the nematode worm, and fission yeast (U2AF59) (14, 24, 36, 43, 56, 66). However, in budding yeast the large subunit is dispensable (1) and the small subunit is absent. U2AF65 interacts with other splicing factors such as BBP/SF1, UAP56, SAP155 (or SF3b155), and SRp54 (1, 10, 15, 39, 64). The branch point binding protein BBP/SF1 binds to the BPS and cooperates with U2AF65 for RNA binding (2, 6).
Detailed in vitro biochemical analyses using model splicing substrates in metazoans have significantly contributed to our mechanistic view of the role of U2AF65 function in splicing. The N terminus of U2AF65 harbors an arginine-serine-rich (RS) activation domain, and its C terminus contains three RNA recognition motifs (RRMs), each with a four-stranded antiparallel ß-sheet and two
-helices (62). In metazoans, binding to the Py tract serves as the primary determinant for U2AF recruitment onto pre-mRNA. This interaction positions the RS domain to engage in a series of interactions with pre-RNA during spliceosome assembly, including stabilization of the base pairing between the BPS and the U2 snRNA (46, 53). U2AF65 is also an important target for splicing regulation, where splicing regulators such as SXL, PTB, hnRNP A1, ASF/SF2, SC35, and TRA can facilitate or antagonize its activity (7, 48).
Whereas U2AF65 is highly conserved from fission yeast to humans, its C-terminal RRM3 domain is the only recognizable portion in the budding yeast protein Mud2p (1). The human RRM3 interacts with BBP/SF1 and SAP155 (or Schizosaccharomyces pombe prp10) (1, 15), and RRM3-related domains are present in several splicing factors (27). Deletion of the conserved RRM3 domain of the large subunit of U2AF (U2AF59) is lethal in S. pombe (4). Intriguingly, RRM3 shows no detectable RNA binding and is not required for the splicing of model substrates in a HeLa cell nuclear extract. RRM1 and RRM2 domains of the human U2AF65 are sufficient for Py tract recognition and in vitro splicing (4). Previously, we proposed that the RRM3 domain might be important for the splicing of only a subset of introns in vivo.
Relative to Saccharomyces cerevisiae, S. pombe shares with mammals many more features of pre-mRNA splicing, including the presence of degenerate splicing signals, similarity of splicing factors (snRNAs and proteins), and a requirement for both subunits of U2AF (U2AF59 and U2AF23) (57, 59). Thus, by combining the power of genomics, molecular genetics, and biochemical analysis, S. pombe represents an excellent model system for analysis of the role of U2AF and Py tract in vivo.
Our study of splicing in S. pombe offers important new information on RRM3 and U2AF functions and Py tract requirements in vivo. There is a large diversity in the arrangement of intronic sequences relevant for 3' splice site recognition, and in the requirements for U2AF subunits and domains, beyond what is known from detailed in vitro biochemical analysis of model pre-mRNAs in metazoans. These findings also help explain why deletion of RRM3 is lethal in S. pombe whereas deletion of the human RRM3 has no effect on RNA binding and on the splicing of model substrates in vitro. Finally, whereas splicing of introns that lack a Py tract remains dependent on U2AF59, upstream Py tracts, located between the 5' splice site and the BPS, are required for splicing in vivo only under conditions of U2AF59 inactivation.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Computational search. The intronic sequence database was downloaded from the S. pombe site (http://www.sanger.ac.uk/Projects/S_pombe/intron.shtml). Nucleotide strings containing 4 to 15 pyrimidines were searched using the regular expression [tc] {4,15} (for details, see reference 13) both upstream and downstream of the annotated BPS (URAY consensus) in the above-named database. Values for the frequency of introns, reflected by the sizes of the bubbles, with respect to the length of the Py tract(s) and its location relative to the annotated BPS were generated for various categories and plotted as shown. The search algorithm was written in Python and is available upon request.
Generation of haploid U2AF59 genomic knockout cells. S. pombe cells were grown in EMM2 containing appropriate amino acids supplements (see the text in the supplemental material) as described in the Fission Yeast Handbook (http://www.sanger.ac.uk/PostGenomics/S_pombe/docs/nurse_lab_manual.pdf). For mutagenesis and genomic integration details, see the text in the supplemental material.
RNA preparation and analysis. The protocols for RNA preparation and semiquantitative reverse transcription-PCR (RT-PCR) (56) were as previously described and used gene-specific primers (primers 17 through 36 [see Table S1 in the supplemental material]). For the quantitative RT-PCR assay, PCR products were stained with SYBR green dye and quantitated using a phosphorimager (Blue and 850V).
| RESULTS |
|---|
|
|
|---|
5.4% of the 4,613 introns analyzed had Py tracts between the BPS and the 3' SS, which is the conventional location of the Py tract (Fig. 1A) (category DY). A significant fraction (51.2%) of introns had Py tracts located upstream of the BPS (between the 5' SS and the BPS; category UY), and 32.8% had Py tracts both upstream and downstream of the BPS (category UDY). Surprisingly, 10.6% had no Py tracts at all (category NY). Our searches for either uridine tracts (a more stringent requirement) or Py tracts with up to two purines (a less stringent sequence requirement) revealed all four categories (data not shown). The S. pombe BPS used for annotation is highly degenerate (YURAY) and is a predicted rather than an experimentally determined element. Thus, if a potential BPS located upstream of the annotated site were used instead, some of the introns labeled as UY or UDY could be DY. While this could result in underestimation of certain categories of introns, the effect, if any, would not be significantly large because, based on computational analysis, it has been argued that the distance between the 5' SS and the BPS provides the major contribution to variability in intron length (28). Moreover, a scanning mechanism similar to that proposed for the recognition of the 3' SS downstream of the BPS in mammals may favor a nearby BPS rather than an additional BPS(s) located further upstream (50). These results indicate that several intronic architectures (or four broad categories) with respect to the length and positions of Py tracts exist in the S. pombe genome. These observations guided the systematic analysis described below with respect to U2AF and RRM3 requirement.
|
Surprisingly, the prp2.1 and U2AF23-ts mutants supported efficient splicing under nonpermissive conditions for the SPBC27 substrate, which has a long natural Py tract between the BPS and the 3' SS (Fig. 1B and C); we considered Py tracts longer than eight consecutive pyrimidines to be long. This contrasts with the conclusion from previous studies using the prp2.1 mutant that the length of the Py tract does not determine responsiveness to U2AF59 in the context of the cdc2.2 intron (41). We found that the prp10 (also known as SAP155) ts mutant (18), however, failed to splice this intron (Fig. 1B), suggesting that a lack of pre-mRNA accumulation in U2AF mutants may not be due simply to preferential pre-mRNA turnover. The spliceosomal factor SAP155 is a core component of the U2 snRNP that interacts with the RRM3 domain of the large subunit of U2AF (15). We conclude that under identical conditions U2AF59 inactivation causes splicing inhibition of the majority of introns but has no detectable effect on an intron with a long Py tract.
Introns lacking a Py tract remain U2AF dependent. It was previously proposed that the presence of a Py tract between the BPS and the 3' SS is not necessary for the involvement of U2AF59 in splicing (41). However, a careful inspection of the four introns used in those studies (cdc2.2, nda3.3, cam1.1, and cgs2.1) revealed that all RNAs have contiguous pyrimidines downstream, upstream, or on both sides of the BPS (Fig. 2B; also see Fig. S1 in the supplemental material), and mutation of only the downstream Py tract of the cdc2.2 intron was previously tested. Therefore, to rigorously test whether introns lacking a Py tract (Fig. 1A, NY) require U2AF activity for splicing in vivo, we chose to test the SPCC16 and cnd3.3 introns because they unambiguously lack Py tracts in the entire intron, with no more than one contiguous pyrimidine downstream of the BPS and no more than two contiguous pyrimidines upstream (Fig. 2B). Based on studies of the large subunit of the metazoan U2AF (21, 42, 49, 61), it is unlikely that U2AF59 would bind directly to these introns with reasonable affinity, although we cannot exclude the possibility that association with BBP/SF1 (22) alters the RNA binding properties of U2AF59. Under nonpermissive conditions, the U2AF59 mutant prp2.1 showed little to no splicing for both introns (Fig. 2Ai), and the U2AF23-ts mutant strain showed no splicing for the cnd3.3 intron. The U2AF23-ts mutation also significantly reduced the splicing of SPCC16 (Fig. 2Ai). In addition, we mutated all potential Py tracts (upstream and downstream of the BPS) in the cdc2.2 intron (Fig. 2B). We found that in the prp2.1 mutant neither the Py tract-less cdc2.2 intron (with mutations of all Py tracts of three or more contiguous pyrimidines; y-none) nor the py-up– cdc2.2 intron (with mutation of upstream three or more contiguous pyrimidines) was spliced (Fig. 2Aii). We chose guanosine substitutions because they represent the most disruptive residue for U2AF65 binding (47, 49). These results indicate that introns lacking Py tracts remain dependent on U2AF activity.
|
|
|
|
|
Length of the Py tract in part influences dependence on RRM3. The above-described experiments suggested that the length of the Py tract could influence RRM3 requirement. To address this issue directly, we used previously generated Py tract mutants of cdc2.2 (41). Consistent with previous results (41), substitution of the conventional Py tract with a long uridine stretch (Y-Long) allowed for efficient splicing in the wild-type background but not in the prp2.1 mutant under nonpermissive conditions (Fig. 6D). Most importantly, whereas the wild-type intron was not spliced, the Y-long mutant was spliced (>50%) in the rrm3-ts mutant. This finding is consistent with our observation that the SPBC27 intron, with a long natural Py tract, was efficiently (100%) spliced in the rrm3-ts mutant. However, the splicing behavior of the Y-long mutant differs in the prp2.1 and rrm3-ts mutants, perhaps because the Py tract is either not as long as those of SPBC27 and ulp2_c introns or is present in a different sequence context. We conclude that certain introns with long Py tracts are efficiently spliced in the rrm3-ts mutant, that our analysis with the rrm3-ts mutant has revealed that U2AF59 is indeed responsive to the length of the Py tract, its sequence composition, and/or its sequence context, and that the requirements for U2AF and RRM3 are not identical. It is tempting to speculate that analysis of additional introns might reveal introns that require U2AF but not RRM3.
Since each of the U2AF mutants (prp2.1, U2AF23-ts, and rrm3-ts) abolished splicing of some introns but had either no detectable effect or only a partial effect on the splicing of others, we interpret these outcomes as reflecting intron-specific differences in the requirements of U2AF subunits or the RRM3 domain rather than merely the strength of a particular allele. Our combined results have important implications for the model of U2AF function.
| DISCUSSION |
|---|
|
|
|---|
|
Role of U2AF in the splicing of introns without a Py tract. The existing model of U2AF function in 3' splice site definition cannot account for why the Py tract-less introns require U2AF59. It has been thought that binding of U2AF65 to the Py tract is the primary determinant for its association with the pre-mRNA, leading to U2 snRNP recruitment. However, introns without Py tracts remain dependent on U2AF activity in S. pombe, implying that U2AF is needed for splicing but must be recruited to the pre-mRNA via a mechanism that does not require Py tract binding. Based on previous studies of metazoans (21, 42, 49, 61), we expect that these intron sequences should exhibit no detectable binding for the RNA binding domain of the large subunit. Although it is possible that a tight association with BBP/SF1 (22) could alter the RNA binding activity of U2AF59 or that the S. pombe U2AF59 and human U2AF65 orthologs differ in sequence preferences, we have been unable to discern any consensus sequence between the BPS and the 3' SS that may serve as unconventional U2AF59 binding site in such introns, including the five introns that were experimentally tested in this study. This scenario of a lack of the Py tract requirement is analogous to the situation seen with S. cerevisiae, where a more efficient interaction of BBP/SF1 with the invariant BPS (UACUAAC), unlike the degenerate consensus (YNCURAY) in mammals, could possibly compensate for a lack of the Py tract or of Mud2p or both (6). Contrary to our expectation, we found that only 8 of 55 randomly selected Py tract-less introns had a perfect BPS (UACUAAC), implying that a stronger BPS may not compensate for a lack of Py tract for most of such introns. Our preliminary experiments show that the recombinant RNA binding domain (RRM1-3) of the S. pombe U2AF59 protein has little or no detectable RNA binding activity (>100-fold lower affinity) in vitro relative to the RRM1-3 domain of the human U2AF65 (see Fig. S4 in the supplemental material). Although a trivial possibility is that the recombinant protein is inactive, it is tempting to speculate that the presence of the RS domain and association of the large subunit with the small subunit (42) and/or the SF1 (22) could influence the RNA binding property of the S. pombe large subunit. Furthermore, requirements for the two U2AF subunits are generally parallel in S. pombe, implying that the two subunits collaborate in vivo (55) (this study). In this respect, the situation seen with S. pombe is different from that in humans, where the large subunit recognizes the 3' SS with long Py tracts (AG-independent introns) without the need for the small subunit, which is important for the AG-dependent introns. Another mechanism may involve bridging interactions across introns involving the small subunit of U2AF and the U1 snRNP 70K protein (60), BPS and U1 snRNP (45), or other factors such as SRp54 (25). We favor the idea that for certain introns these interactions could indeed provide a major contribution, as an alternative to the widely held view centering on the U2AF large subunit-Py tract, to early events during 3' splice site definition. We propose that a variety of early interactions contribute to 3' splice site recognition for different intron architectures (Fig. 7).
How do upstream Py tracts function? The current model does not explain how upstream Py tracts function in constitutive splicing and why they become important only upon U2AF59 inactivation. There are two possible explanations for why some introns are unaffected upon U2AF inactivation. First, certain introns in S. pombe (and possibly in metazoans) are U2AF independent and involve a U2AF-Py tract-independent splicing mechanism for 3' splice site definition in vivo. Although this may be regarded as a radical view, considering an essential requirement of U2AF65 in splicing, this proposal is indeed similar to that addressing the exceptional situation in S. cerevisiae, where both Mud2p and the Py tract are generally dispensable for splicing (1, 35). It is also known that certain introns can be spliced in U2AF-depleted extracts under unusual in vitro conditions such as an excess of SR proteins or in extracts prepared from adenovirus-infected cells (31, 32), and an E-like splicing complex (E') has been observed in the absence of U2AF (26). Moreover, the U12-type (minor) introns lack a Py tract, and thus U2AF is unlikely to facilitate association of U12 snRNP with the BPS (58). Second, such introns could be U2AF dependent, because under nonpermissive conditions the prp2.1 mutant may retain residual U2AF activity (a limitation also applicable to biochemical depletion of U2AF in vitro) and both introns that are unaffected by U2AF mutations have long Py tracts. This residual activity could have supported the splicing of these introns, presumably because unusually long Py tracts offer multiple registers for binding and thus increased affinity to compensate for reduced U2AF activity (3). Splicing inhibition in this scenario requires, akin to a synthetic phenotype, a combination of Py tract mutation and U2AF inactivation. The experiments described here cannot distinguish whether the upstream Py tract binds U2AF directly or binds another factor such as SRp54, TIA-1-like, or Nam-8p-like proteins (Fig. 7, UY panel, factor x) to facilitate 5' splice site and/or BPS recognition (11, 12, 25, 38), after which U1 snRNP can then support SF1/U2AF recruitment (2, 8, 30, 63). We note that the introns with upstream Py tracts tested here have optimal 5' SS and are constitutively spliced, which differs from findings of the presence of suboptimal 5' splice sites in examples of TIA-1- and Nam8p-sensitive regulated introns. The upstream Py tract could also function by providing a favorable sequence context. If U2AF functions from these upstream Py tracts, it could easily facilitate a series of sequential interactions between the RS domain and splicing signals during spliceosome assembly (Fig. 7, UY panel) as recently proposed by Shen and Green (46). Although the Py tract in the proposed model is located on the other side of the BPS, it could nonetheless serve to bind RRM1 and RRM2 and bring the RS and/or RRM3 domain in proximity to the BPS. This is feasible because the RNA chain is flexible and the RRM3 and RS domains are tethered via extended flexible linker sequences, which could permit U2AF function in a location-independent manner, akin to how activators work from either upstream or downstream enhancers to promote relevant steps during the assembly of multiprotein splicing (or transcription) complexes (20, 37).
Role of RRM3 in splicing. We have shown that whereas the majority of fission yeast introns require RRM3, certain introns are insensitive to RRM3 inactivation in vivo. Whereas the human RRM3 is dispensable for model introns with short and long Py tracts in vitro (4), a requirement for RRM3 is sensitive to Py tract length (and possibly sequence composition and sequence context) in S. pombe. Although interactions of RRM3 with BBP/SF1 and SAP155 could explain the sequence conservation of RRM3 as well as synthetic lethality of S. cerevisiae mud2 with other components of the splicing machinery (1, 2, 6, 15, 62), our favored explanation is that during spliceosome assembly RRM3 is required for a step(s) that may be rate limiting for only a subset of introns and that RRM3 (or its interactions with other splicing factors) likely plays a kinetic rather than an essential role. This assertion is supported by several observations. First, a USx chimera (of U2AF65 and SXL) lacking RRM3 supports splicing of a 3' splice site associated with a 17-nucleotide-long Py tract in a HeLa extract and in transgenic flies (16, 54). This is most likely because a higher affinity of USx for a rather long Py tract allows it to overcome a rate-limiting step that requires RRM3. Second, the S. cerevisiae ortholog Mud2p containing RRM3 as the only recognizable portion of U2AF65 is dispensable (1). Third, the RRM3 interacting partner SF1/BBP has a kinetic rather than an essential role in splicing and U2 snRNP binding in S. cerevisiae and humans (17, 44). In addition to the kinetic role of the RRM3-SF1 interaction, the potential RRM3-dependent rate-limiting process could contribute to subsequent steps during spliceosome assembly, such as recognition of the BPS by the U2 snRNP or any function prior to U2AF release from the spliceosome (5).
Biological importance—spliceosome assembly pathways beyond model substrates. Development of an in vitro splicing system and characterization of model pre-mRNA substrates contributed enormously to the identification of splicing signals, factors, and a spliceosome assembly pathway(s). However, findings obtained with model substrates may not explain every instance of splicing. Numerous intronic sequence arrangements for 3' splice site recognition exist; these may differ with respect to the length, strength, spacing, and sequence contexts of cis-acting splicing elements. Similarly, there are cell- and tissue-specific differences with respect to the concentration, activity, localization, and interacting partners for splicing factors and the presence or absence of splicing activators and repressors. Whereas these features obviously generate a highly complex landscape of assembly pathways with respect to requirements for cis- and trans-acting elements, studies with model substrates have captured only a limited fraction of the entire spectrum that actually exists. The presence of a large array of intron architectures and of requirements for trans-acting factors increases the potential for the generation of enormous diversity for molecular functions and/or regulation via combinatorial control (29, 48), which has played an important role during metazoan evolution. At the same time, these features increase the degree of freedom in regard to associations of cis- and trans-acting elements, thereby complicating intron-exon identification in eukaryotic genomes and contributing to peculiar splicing behaviors of introns.
These studies reinforce the notion that the spliceosome assembly pathway is flexible, that different pre-mRNAs likely have distinct rate-limiting steps, and that alternative (U1-, U2AF-, and RRM3-insensitive) spliceosome assembly pathways exist (4, 9, 32, 51, 52). Whether a splicing factor, a domain, or a particular assembly pathway is essential, dispensable, or partially required for splicing may not be absolute for each and every intron. Moreover, strengthening or weakening of one or more of the numerous potential interactions in different contexts could modify the need for other interactions. In conclusion, versatility of initial interactions early during spliceosomal assembly within the same species exists to accommodate a variety of intron architectures. This phenomenon is relevant not only for splicing but also for many steps along the gene expression pathway (transcription, RNA processing, translation, and signaling).
| ACKNOWLEDGMENTS |
|---|
This work was supported in part by grants from the American Cancer Society, the Keck Foundation, and the National Institutes of Health to R.S.
| FOOTNOTES |
|---|
Published ahead of print on 20 August 2007. ![]()
Supplemental material for this article may be found at http://mcb.asm.org/. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Abovich, N., and M. Rosbash. 1997. Cross-intron bridging interactions in the yeast commitment complex are conserved in mammals. Cell 89:403-412.[CrossRef][Medline]
3. Banerjee, H., A. Rahn, W. Davis, and R. Singh. 2003. Sex lethal and U2 small nuclear ribonucleoprotein auxiliary factor (U2AF65) recognize polypyrimidine tracts using multiple modes of binding. RNA 9:88-99.
4. Banerjee, H., A. Rahn, B. Gawande, S. Guth, J. Valcárcel, and R. Singh. 2004. The conserved RNA Recognition Motif 3 of U2 snRNA Auxiliary Factor (U2AF65) is essential in vivo but dispensable for activity in vitro. RNA 10:240-253.
5. Bennett, M., S. Michaud, J. Kingston, and R. Reed. 1992. Protein components specifically associated with prespliceosome and spliceosome complexes. Genes Dev. 6:1986-2000.
6. Berglund, J. A., N. Abovich, and M. Rosbash. 1998. A cooperative interaction between U2AF65 and mBBP/SF1 facilitates branchpoint region recognition. Genes Dev. 12:858-867.
7. Black, D. L. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72:291-336.[CrossRef][Medline]
8. Côté, J., J. Beaudoin, R. Tacke, and B. Chabot. 1995. The U1 small nuclear ribonucleoprotein/5' splice site interaction affects U2AF65 binding to the downstream 3' splice site. J. Biol. Chem. 270:4031-4036.
9. Crispino, J. D., B. J. Blencowe, and P. A. Sharp. 1994. Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP. Science 265:1866-1869.
10. Fleckner, J., M. Zhang, J. Valcárcel, and M. R. Green. 1997. U2AF65 recruits a novel human DEAD box protein required for the U2 snRNP-branchpoint interaction. Genes Dev. 11:1864-1872.
11. Förch, P., L. Merendino, C. Martinez, and J. Valcárcel. 2003. U2 small nuclear ribonucleoprotein particle (snRNP) auxiliary factor of 65 kDa, U2AF65, can promote U1 snRNP recruitment to 5' splice sites. Biochem. J. 372:235-240.[CrossRef][Medline]
12. Förch, P., O. Puig, N. Kedersha, C. Martinez, S. Granneman, B. Seraphin, P. Anderson, and J. Valcárcel. 2000. The apoptosis-promoting factor TIA-1 is a regulator of alternative pre- mRNA splicing. Mol. Cell 6:1089-1098.[CrossRef][Medline]
13. Friedl, J. E. F. 1997. Mastering regular expressions. O'Reilly and Associates, Sebastopol, CA.
14. Golling, G., A. Amsterdam, Z. Sun, M. Antonelli, E. Maldonado, W. Chen, S. Burgess, M. Haldi, K. Artzt, S. Farrington, S. Y. Lin, R. M. Nissen, and N. Hopkins. 2002. Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development. Nat. Genet. 31:135-140.[CrossRef][Medline]
15. Gozani, O., J. Potashkin, and R. Reed. 1998. A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site. Mol. Cell. Biol. 18:4752-4760.
16. Granadino, B., L. O. F. Penalva, M. R. Green, J. Valcárcel, and L. Sanchez. 1997. Distinct mechanisms of splicing regulation in vivo by the Drosophila protein Sex-lethal. Proc. Natl. Acad. Sci. USA 94:7343-7348.
17. Guth, S., and J. Valcárcel. 2000. Kinetic role for mammalian SF1/BBP in spliceosome assembly and function after polypyrimidine tract recognition by U2AF. J. Biol. Chem. 275:38059-38066.
18. Habara, Y., S. Urushiyama, T. Tani, and Y. Ohshima. 1998. The fission yeast prp10(+) gene involved in pre-mRNA splicing encodes a homologue of highly conserved splicing factor, SAP155. Nucleic Acids Res. 26:5662-5669.
19. Hastings, M. L., and A. R. Krainer. 2001. Pre-mRNA splicing in the new millennium. Curr. Opin. Cell Biol. 13:302-309.[CrossRef][Medline]
20. Hertel, K. J., K. W. Lynch, and T. Maniatis. 1997. Common themes in the function of transcription and splicing enhancers. Curr. Opin. Cell Biol. 9:350-357.[CrossRef][Medline]
21. Hollins, C., D. A. Zorio, M. MacMorris, and T. Blumenthal. 2005. U2AF binding selects for the high conservation of the C. elegans 3' splice site. RNA 11:248-253.
22. Huang, T., J. Vilardell, and C. C. Query. 2002. Pre-spliceosome formation in S. pombe requires a stable complex of SF1-U2AF(59)-U2AF(23). EMBO J. 21:5516-5526.[CrossRef][Medline]
23. Jurica, M. S., and M. J. Moore. 2003. Pre-mRNA splicing: awash in a sea of proteins. Mol. Cell 12:5-14.[CrossRef][Medline]
24. Kanaar, R., S. E. Roche, E. L. Beall, M. R. Green, and D. C. Rio. 1993. The conserved pre-mRNA splicing factor U2AF from Drosophila: requirement for viability. Science 262:569-573.
25. Kennedy, C. F., A. Kramer, and S. M. Berget. 1998. A role for SRp54 during intron bridging of small introns with pyrimidine tracts upstream of the branch point. Mol. Cell. Biol. 18:5425-5434.
26. Kent, O. A., D. B. Ritchie, and A. M. Macmillan. 2005. Characterization of a U2AF-independent commitment complex (E') in the mammalian spliceosome assembly pathway. Mol. Cell. Biol. 25:233-240.
27. Kielkopf, C. L., S. Lucke, and M. R. Green. 2004. U2AF homology motifs: protein recognition in the RRM world. Genes Dev. 18:1513-1526.
28. Kupfer, D. M., S. D. Drabenstot, K. L. Buchanan, H. Lai, H. Zhu, D. W. Dyer, B. A. Roe, and J. W. Murphy. 2004. Introns and splicing elements of five diverse fungi. Eukaryot. Cell 3:1088-1100.
29. Levine, M., and R. Tjian. 2003. Transcription regulation and animal diversity. Nature 424:147-151.[CrossRef][Medline]
30. Li, Y., and B. J. Blencowe. 1999. Distinct factor requirements for exonic splicing enhancer function and binding of U2AF to the polypyrimidine tract. J. Biol. Chem. 274:35074-35079.
31. Lützelberger, M., E. Backstrom, and G. Akusjarvi. 2005. Substrate-dependent differences in U2AF requirement for splicing in adenovirus-infected cell extracts. J. Biol. Chem. 280:25478-25484.
32. MacMillan, A. M., P. S. McCaw, J. D. Crispino, and P. A. Sharp. 1997. SC35-mediated reconstitution of splicing in U2AF-depleted nuclear extract. Proc. Natl. Acad. Sci. USA 94:133-136.
33. Merendino, L., S. Guth, D. Bilbao, C. Martinez, and J. Valcárcel. 1999. Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3' splice site AG. Nature 402:838-841.[CrossRef][Medline]
34. Moore, M. J. 2000. Intron recognition comes of AGe. Nat. Struct. Biol. 7:14-16.[CrossRef][Medline]
35. Patterson, B., and C. Guthrie. 1991. A U-rich tract enhances usage of an alternative 3' splice site in yeast. Cell 64:181-187.[CrossRef][Medline]
36. Potashkin, J., K. Naik, and K. Wentz-Hunter. 1993. U2AF homolog required for splicing in vivo. Science 262:573-575.
37. Ptashne, M., and A. Gann. 1997. Transcriptional activation by recruitment. Nature 386:569-577.[CrossRef][Medline]
38. Puig, O., A. Gottschalk, P. Fabrizio, and B. Seraphin. 1999. Interaction of the U1 snRNP with nonconserved intronic sequences affects 5' splice site selection. Genes Dev. 13:569-580.
39. Rain, J. C., Z. Rafi, Z. Rhani, P. Legrain, and A. Kramer. 1998. Conservation of functional domains involved in RNA binding and protein-protein interactions in human and Saccharomyces cerevisiae pre-mRNA splicing factor SF1. RNA 4:551-565.[Abstract]
40. Reed, R. 2000. Mechanisms of fidelity in pre-mRNA splicing. Curr. Opin. Cell Biol. 12:340-345.[CrossRef][Medline]
41. Romfo, C. M., S. Lakhe-Reddy, and J. A. Wise. 1999. Molecular genetic analysis of U2AF59 in Schizosaccharomyces pombe: differential sensitivity of introns to mutational inactivation. RNA 5:49-65.[Abstract]
42. Rudner, D. Z., K. S. Breger, R. Kanaar, M. D. Adams, and D. C. Rio. 1998. RNA binding activity of heterodimeric splicing factor U2AF: at least one RS domain is required for high-affinity binding. Mol. Cell. Biol. 18:4004-4011.
43. Rudner, D. Z., R. Kanaar, K. S. Breger, and D. C. Rio. 1996. Mutations in the small subunit of the Drosophila U2AF splicing factor cause lethality and developmental defects. Proc. Natl. Acad. Sci. USA 93:10333-10337.
44. Rutz, B., and B. Seraphin. 2000. A dual role for BBP/ScSF1 in nuclear pre-mRNA retention and splicing. EMBO J. 19:1873-1886.[CrossRef][Medline]
45. Seraphin, B., and M. Rosbash. 1989. Identification of functional U1 snRNA-pre-mRNA complexes committed to spliceosome assembly and splicing. Cell 59:349-358.[CrossRef][Medline]
46. Shen, H., and M. R. Green. 2004. A pathway of sequential arginine-serine-rich domain-splicing signal interactions during mammalian spliceosome assembly. Mol. Cell 16:363-373.[CrossRef][Medline]
47. Singh, R., H. Banerjee, and M. R. Green. 2000. Differential recognition of the polypyrimidine-tract by the general splicing factor U2AF65 and the splicing repressor sex-lethal. RNA 6:901-911.[Abstract]
48. Singh, R., and J. Valcárcel. 2005. Building specificity with nonspecific RNA-binding proteins. Nat. Struct. Mol. Biol. 12:645-653.[CrossRef][Medline]
49. Singh, R., J. Valcárcel, and M. R. Green. 1995. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268:1173-1176.
50. Smith, C. W., T. T. Chu, and B. Nadal-Ginard. 1993. Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns. Mol. Cell. Biol. 13:4939-4952.
51. Tange, T. O., C. K. Damgaard, S. Guth, J. Valcárcel, and J. Kjems. 2001. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO J. 20:5748-5758.[CrossRef][Medline]
52. Tarn, W. Y., and J. A. Steitz. 1994. SR proteins can compensate for the loss of U1 snRNP functions in vitro. Genes Dev. 8:2704-2717.
53. Valcárcel, J., R. K. Gaur, R. Singh, and M. R. Green. 1996. Interaction of U2AF65 RS region with pre-mRNA branch point and promotion of base pairing with U2 snRNA. Science 273:1706-1709.
54. Valcárcel, J., R. Singh, P. D. Zamore, and M. R. Green. 1993. The protein Sex-lethal antagonizes the splicing factor U2AF to regulate alternative splicing of transformer pre-mRNA. Nature 362:171-175.[CrossRef][Medline]
55. Webb, C. J., S. Lakhe-Reddy, C. M. Romfo, and J. A. Wise. 2005. Analysis of mutant phenotypes and splicing defects demonstrates functional collaboration between the large and small subunits of the essential splicing factor U2AF in vivo. Mol. Biol. Cell 16:584-596.
56. Webb, C. J., and J. A. Wise. 2004. The splicing factor U2AF small subunit is functionally conserved between fission yeast and humans. Mol. Cell. Biol. 24:4229-4240.
57. Wentz-Hunter, K., and J. Potashkin. 1995. The evolutionary conservation of the splicing apparatus between fission yeast and man. Nucleic Acids Symp. Ser. 33:226-228.
58. Will, C. L., C. Schneider, R. Reed, and R. Luhrmann. 1999. Identification of both shared and distinct proteins in the major and minor spliceosomes. Science 284:2003-2005.
59. Wood, V., et al. 2002. The genome sequence of Schizosaccharomyces pombe. Nature 415:871-880.[CrossRef][Medline]
60. Wu, J. Y., and T. Maniatis. 1993. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75:1061-1070.[CrossRef][Medline]
61. Wu, S., C. M. Romfo, T. W. Nilsen, and M. R. Green. 1999. Functional recognition of the 3' splice site AG by the splicing factor U2AF35. Nature 402:832-835.[CrossRef][Medline]
62. Zamore, P. D., J. G. Patton, and M. R. Green. 1992. Cloning and domain structure of the mammalian splicing factor U2AF. Nature 355:609-614.[CrossRef][Medline]
63. Zhang, D., and M. Rosbash. 1999. Identification of eight proteins that cross-link to pre-mRNA in the yeast commitment complex. Genes Dev. 13:581-592.
64. Zhang, W. J., and J. Y. Wu. 1996. Functional properties of p54, a novel SR protein active in constitutive and alternative splicing. Mol. Cell. Biol. 16:5400-5408.[Abstract]
65. Zorio, D. A., and T. Blumenthal. 1999. Both subunits of U2AF recognize the 3' splice site in Caenorhabditis elegans. Nature 402:835-838.[CrossRef][Medline]
66. Zorio, D. A., and T. Blumenthal. 1999. U2AF35 is encoded by an essential gene clustered in an operon with RRM/cyclophilin in Caenorhabditis elegans. RNA 5:487-494.[Abstract]
| ||||||||||||||||||||||||||||||||||||||||||||||